Market Access and Phase IV Solutions
Covance Market Access and Phase IV Solutions has the experience and forward thinking to help you ensure patient safety and access, while maximizing your product’s value and commercial success.
No matter where your product is in its lifecycle, we work with you to maximize its clinical and commercial value. Over the last 30 years, Covance has established a complete, comprehensive portfolio of services to optimize patient support, adherence and product access, leveraging RWE and innovative Phase IV studies to demonstrate value, efficacy, and safety to payers, prescribers and regulatory bodies, as well as providing a world leading safety solutions portfolio. From the following broad categories, Covance builds flexible solutions to address the unique challenges of your products and therapy areas
At Covance Market Access, we start by listening carefully and understanding your needs. Then we apply our industry expertise to develop customized solutions that make sense for your organization.
Contact the Covance Market Access team in Asia-Pacific.